Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early-Stage Breast Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00943670
What this trial is testing

Corrected QT Interval Effects of Trastuzumab Emtansine (T-DM1) in Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced or Metastatic Breast Cancer and the Safety and Tolerability of Combined T-DM1 and Pertuzumab in Patients With Early Disease Progression

Who this might be right for
Metastatic Breast Cancer
Genentech, Inc. 51
Not applicableNot Yet RecruitingNCT07072156
What this trial is testing

The Effect of Stress Ball Use on Stress, Anxiety, and Vital Signs in Patients Undergoing Chemotherapy for Breast Cancer

Who this might be right for
ChemotherapyBreast Cancer Early Stage Breast Cancer (Stage 1-3)
Ataturk University 50
Testing effectiveness (Phase 2)Looking for participantsNCT06107673
What this trial is testing

Dalpiciclib Plus AI (Neoadjuvant Endocrine Therapy) Compared With Neoadjuvant Chemotherapy in Early Breast Cancer （EBC）

Who this might be right for
Breast Cancer
Hebei Medical University Fourth Hospital 144
Large-scale testing (Phase 3)Study completedNCT04024462
What this trial is testing

A Two-Arm Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Chinese Participants With HER2-Positive Early Breast Cancer

Who this might be right for
HER2-positive Early Breast Cancer
Hoffmann-La Roche 200
Testing effectiveness (Phase 2)Study completedNCT01484080
What this trial is testing

Neoadjuvant Paclitaxel Versus BIBF 1120 Priming Followed by BIBF 1120 Plus Paclitaxel in Early HER-2 Negative Breast Cancer With Proteomic and Dynamic Imaging Correlates

Who this might be right for
Breast Cancer
Centro Nacional de Investigaciones Oncologicas CARLOS III 140
Not applicableLooking for participantsNCT05935150
What this trial is testing

Omission of SLNB in CN0 Early Breast Cancer

Who this might be right for
Breast CancerClinically Assessed Negative Axillary Lymph NodesSentinel Lymph Node
The First Affiliated Hospital with Nanjing Medical University 311
Large-scale testing (Phase 3)UnknownNCT01064635
What this trial is testing

Letrozole in Treating Breast Cancer in Postmenopausal Women With Stage I, II, or III Breast Cancer Previously Treated With Tamoxifen (GIM4)

Who this might be right for
Breast Cancer
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy 2,056
Not applicableWithdrawnNCT06610097
What this trial is testing

TNBC Gut Microbiota During Neoadjuvant Treatment

Who this might be right for
Breast CancerTriple Negative Breast CancerEarly Stage Triple-Negative Breast Carcinoma
Scripps Health
Not applicableNot Yet RecruitingNCT07657442
What this trial is testing

Risk-Stratified Hypofractionated Radiotherapy After Breast-Conserving Surgery for Early Breast Cancer

Who this might be right for
Early Stage Breast CarcinomaBreast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 649
Not applicableUnknownNCT05280288
What this trial is testing

Effect of the App Bone@BC Version 4.0 Under the Follow-up for Patients With Early Breast Cancer

Who this might be right for
Early-stage Breast Cancer
Rigshospitalet, Denmark 120
Not applicableStudy completedNCT01928186
What this trial is testing

FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast Cancer

Who this might be right for
Estrogen Receptor PositiveHER2/Neu NegativeMale Breast Carcinoma+7 more
University of Washington 28
Not applicableLooking for participantsNCT07107594
What this trial is testing

Multimodal Prehabilitation Program That Combines Physical Exercise, Psychological Intervention and Nutritional Support to Improve the Response to Neoadjuvant Chemoterhapy in Early Breast Cancer Patients

Who this might be right for
Breast Cancer Early Stage Breast Cancer (Stage 1-3)Prehabilitation
Hospital Clinic of Barcelona 214
Not applicableStudy completedNCT00584142
What this trial is testing

Mindfulness-based Stress Reduction in Breast Cancer Recovery

Who this might be right for
Breast Cancer
University of South Florida 84
Not applicableStudy completedNCT04148586
What this trial is testing

Trial Comparing 3 Schedules of Hypofractionated Whole Breast Irradiation in Females With Early Stage Breast Cancer

Who this might be right for
Breast Cancer Female
National Cancer Institute, Egypt 152
Testing effectiveness (Phase 2)UnknownNCT02095743
What this trial is testing

Tolerance of PICC Line Versus Implanted Port for Adjuvant Chemotherapy in Early Breast Cancer

Who this might be right for
Early Stage Breast Carcinoma
Centre Henri Becquerel 256
Large-scale testing (Phase 3)Study completedNCT00309491
What this trial is testing

Randomized Study Comparing Tamoxifen vs. Tamoxifen + Aminoglutethimide in Postmenopausal Receptor-positive Patients

Who this might be right for
Early-stage Breast Cancer
Austrian Breast & Colorectal Cancer Study Group 2,021
Large-scale testing (Phase 3)Ended earlyNCT04588246
What this trial is testing

Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Lung Non-Small Cell CarcinomaMetastatic Lung Small Cell Carcinoma+9 more
NRG Oncology 19
Large-scale testing (Phase 3)Study completedNCT01108016
What this trial is testing

Expanding Rural Access: Distance Delivery of Support Groups (Main Study)

Who this might be right for
DepressionBreast CancerStress+3 more
Stanford University 100
Not applicableStudy completedNCT02625935
What this trial is testing

Prospective Observational Study Evaluating Treatment Decision Impact of Prosigna® in Early Stage Breast Cancer Patients

Who this might be right for
Breast Cancer
NanoString Technologies, Inc. 206
Not applicableUnknownNCT02947425
What this trial is testing

TARGeted Intraoperative radioTherapy (TARGIT) Registry Database

Who this might be right for
Early-Stage Breast Carcinoma
University College, London 2,000
Next Page